This study is looking at estimate, from a collective point of view, the incremental cost-utility ratio of VNS to treat patients suffering from RD for people with Treatment Resistant Depression. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether problem-solving support can help people with depression or Cognitive Dysfunction. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at whether a digital support tool can help people with depression. Participants take part in a digital support tool and complete follow-up assessments.
In Shanghai
Why is this study shown?
This study is directly about Depression.
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
This study is looking at whether a digital support tool can help people with Postpartum depression, depression, and healthy postpartum women or Mental and Behavioural Disorders. Participants take part in a digital support tool and complete follow-up assessments.
This observational study is following people with Major Depression or Sleep Inertia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing Neurostimulation System (NSS): Active Setting with Sham Neurostimulation System (NSS) for people with depression or Treatment Resistant Depression. Participants receive Neurostimulation System (NSS): Active Setting or Sham Neurostimulation System (NSS) and complete study visits and assessments.
This observational study is following people with depression, Depression in Children, or Depressive Symptoms to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.